AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35130342 — intervention group
Group type: EXPERIMENTAL
Intervention: Gilteritinib
Number of subjects: 0
Study 35130342 — intervention group
Group type: COMPARATOR
Intervention: Salvage Chemotherapy (SC)
Number of subjects: 0
Study 32178231 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame group (EG) - virtually supervised intradialytic exercise program
Number of subjects: 73
Study 32178231 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise group (SG) - nurse-supervised intradialytic exercise
Number of subjects: 73
Study 34998232 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual shopping training
Number of subjects: 32
Study 34998232 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 32
Study 34129715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton
Number of subjects: 8
Study 34129715 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE)
Number of subjects: 8
Study 34129715 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic foam
Number of subjects: 8
Study 34129715 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvinyl siloxane (PVS)
Number of subjects: 8
Study 32859607 — intervention group
Group type: EXPERIMENTAL
Intervention: rtCGM (Guardian Connect Mobile)
Number of subjects: 60
Study 32859607 — intervention group
Group type: COMPARATOR
Intervention: isCGM (FreeStyle Libre)
Number of subjects: 60
Study 33664157 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP+MI
Number of subjects: 30
Study 33664157 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP
Number of subjects: 30
Study 33664157 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP+cMI
Number of subjects: 30
Study 33148720 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced 6-month intervention package (one face-to-face physiotherapy assessment, tailored physical activity plan, physical activity phone coaching from a physiotherapist, informational/motivational resources and activity monitors)
Number of subjects: 600
Study 33148720 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive 6-month intervention package (single session of tailored phone advice from a physiotherapist, tailored physical activity plan, unidirectional text messages, informational/motivational resources)
Number of subjects: 600
Study 33148720 — intervention group
Group type: COMPARATOR
Intervention: Enhanced intervention package
Number of subjects: 600
Study 33148720 — intervention group
Group type: COMPARATOR
Intervention: Less intensive intervention package
Number of subjects: 600
Study 35110309 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand-alone mobile mindfulness app for 3 months
Number of subjects: 60
Study 35110309 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 60
Study 34582701 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy (asana and pranayama practice for 12 weeks)
Number of subjects: 80
Study 34582701 — intervention group
Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OAD) alone
Number of subjects: 80
Study 32887762 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined scatter correction (CC)
Number of subjects: 20
Study 32887762 — intervention group
Group type: COMPARATOR
Intervention: No correction (NC)
Number of subjects: 20
Study 32887762 — intervention group
Group type: COMPARATOR
Intervention: Scatter correction (SC)
Number of subjects: 20
Study 32887762 — intervention group
Group type: COMPARATOR
Intervention: Attenuation correction (AC)
Number of subjects: 20
Study 36371189 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral scanning of the scan body
Number of subjects: 8
Study 36371189 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional closed tray impression technique
Number of subjects: 8
Study 36371189 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional open tray impression technique
Number of subjects: 8
Study 36371189 — intervention group
Group type: COMPARATOR
Intervention: Reference group (intraoral scanning of the abutment)
Number of subjects: 8
Study 32088110 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic surgery
Number of subjects: 57
Study 34972039 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 42
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: Pan-immunoglobulins against SARS-CoV-2
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM antibodies
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: IgA antibodies
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralising antibodies
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralising antibodies over time
Number of subjects: 9702
Study 33743869 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies over time
Number of subjects: 9702
Study 35488213 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) and Motor Imagery (MI) in addition to Physical Therapy (PT)
Number of subjects: 44
Study 35488213 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (PT)
Number of subjects: 44
Study 32028501 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered lidocaine
Number of subjects: 125
Study 32028501 — intervention group
Group type: COMPARATOR
Intervention: Nonbuffered lidocaine
Number of subjects: 125
Study 34226926 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - Lower second molar tubes bonded at the time of 0.016" x 0.022" NiTi wire placement
Number of subjects: 36
Study 34226926 — intervention group
Group type: COMPARATOR
Intervention: Group B - Lower second molars bonded at the first appointment
Number of subjects: 36
Study 33579288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (long-acting beta-2 agonist [LABA] or long-acting muscarinic antagonist [LAMA]) in GOLD III/IV group
Number of subjects: 14449
Study 33579288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy in GOLD III/IV group
Number of subjects: 14449
Study 33579288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy in GOLD I/II group
Number of subjects: 14449
Study 32005334 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT combined with the smartphone application
Number of subjects: 150
Study 32005334 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT
Number of subjects: 150
Study 32005334 — intervention group
Group type: COMPARATOR
Intervention: Behavioral support
Number of subjects: 150
Study 33836476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ACTH
Number of subjects: 65
Study 33836476 — intervention group
Group type: COMPARATOR
Intervention: Oral Prednisolone
Number of subjects: 65
Study 32635790 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted hemoglobin
Number of subjects: 265424
Study 35988661 — intervention group
Group type: EXPERIMENTAL
Intervention: sEMG-BF (surface EMG biofeedback)
Number of subjects: 80
Study 35988661 — intervention group
Group type: COMPARATOR
Intervention: continued care (no intervention)
Number of subjects: 80
Study 33639999 — intervention group
Group type: EXPERIMENTAL
Intervention: Endosonography without confirmatory mediastinoscopy
Number of subjects: 0
Study 33639999 — intervention group
Group type: COMPARATOR
Intervention: Endosonography with confirmatory mediastinoscopy
Number of subjects: 0
Study 34009907 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 32
Study 34009907 — intervention group
Group type: COMPARATOR
Intervention: Postsimulation Debriefing (PSD)
Number of subjects: 32
Study 32041441 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling with topical tacrolimus at 2 weeks intervals for a maximum of 6 months
Number of subjects: 48
Study 32041441 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus 0.1% ointment applied once daily for 6 months
Number of subjects: 48
Study 32041441 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling with topical tacrolimus
Number of subjects: 48
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Synoptic reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban hospital settings
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Time (2005 vs 2010)
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Synoptic reporting adoption (2005 vs 2010)
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence to guidelines
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor histologic grade reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial margin reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance from the closest margin reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment effect reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphovascular invasion reporting
Number of subjects: 1004
Study 32692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural invasion reporting
Number of subjects: 1004
Study 36031846 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone irrigation (4 ml of 40mg/ml solution)
Number of subjects: 58
Study 36031846 — intervention group
Group type: COMPARATOR
Intervention: Saline irrigation (control)
Number of subjects: 58
Study 34397028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive retainer group
Number of subjects: 38
Study 34397028 — intervention group
Group type: COMPARATOR
Intervention: Modified adhesive retainer group
Number of subjects: 38
Study 34397028 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 34698502 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Genotypic Resistance Testing (GRT)
Number of subjects: 840
Study 34698502 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 840
Study 32107270 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily sunscreen use (prevention)
Number of subjects: 100000
Study 32107270 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual clinical skin examinations (early detection)
Number of subjects: 100000
Study 32107270 — intervention group
Group type: COMPARATOR
Intervention: No intervention (status quo)
Number of subjects: 100000
Study 34893415 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-starch high-fiber pasta (LSHFP)
Number of subjects: 20
Study 34893415 — intervention group
Group type: COMPARATOR
Intervention: Rice
Number of subjects: 20
Study 34893415 — intervention group
Group type: COMPARATOR
Intervention: Standard pasta (SP)
Number of subjects: 20
Study 34162968 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 2
Study 34162968 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 2
Study 32326347 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei HA-196 (n = 84)
Number of subjects: 251
Study 32326347 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum R0175 (n = 83)
Number of subjects: 251
Study 32326347 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 81)
Number of subjects: 251
Study 33651733 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill GXT
Number of subjects: 31
Study 33651733 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle GXT
Number of subjects: 31
Study 32792358 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune-checkpoint-blockade (ICB) treatment
Number of subjects: 93
Study 32792358 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinatorial biomarker of tumor mutational burden (TMB) and CNA
Number of subjects: 93
Study 32792358 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower burden of CNA
Number of subjects: 93
Study 32792358 — intervention group
Group type: EXPERIMENTAL
Intervention: CNA burden
Number of subjects: 93
Study 35792746 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine (3 doses)
Number of subjects: 0
Study 35792746 — intervention group
Group type: EXPERIMENTAL
Intervention: BA.1 convalescent sera
Number of subjects: 0
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: n-3 fatty acids during the grower phase (11-24 d)
Number of subjects: 210
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: n-3 fatty acids during the starter phase (0-10 d)
Number of subjects: 210
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: VE (200 IU/kg) and n-3 fatty acids during the grower phase (11-24 d)
Number of subjects: 210
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: Combination of VE and n-3 fatty acids
Number of subjects: 210
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: VE during the starter phase (0-10 d)
Number of subjects: 210
Study 33518304 — intervention group
Group type: COMPARATOR
Intervention: Control group (corn-soybean meal-basal diet)
Number of subjects: 210
Study 32139502 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher IOP fluctuation
Number of subjects: 127
Study 32139502 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater mean IOP reduction post-trabeculectomy
Number of subjects: 127
Study 32139502 — intervention group
Group type: COMPARATOR
Intervention: Intra-operative 5-FU
Number of subjects: 127
Study 35276809 — intervention group
Group type: EXPERIMENTAL
Intervention: Food and Nutrition Education Program with Sensory and Cognitive Exercises
Number of subjects: 37
Study 35276809 — intervention group
Group type: COMPARATOR
Intervention: Waiting period (control group)
Number of subjects: 37
Study 33759640 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanol-gasoline blend 12% (M12)
Number of subjects: 1
Study 33759640 — intervention group
Group type: COMPARATOR
Intervention: Methanol-gasoline blends (0%, 3%, 6%, 9%, 12%, 15%, 18%)
Number of subjects: 1
Study 32702891 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injection (1 mL of 0.5% bupivacaine and 10 mg of triamcinolone acetonide)
Number of subjects: 90
Study 32702891 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 mL of 0.5% bupivacaine and 1 mL of normal saline)
Number of subjects: 90
Study 32702891 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injection
Number of subjects: 90
Study 35380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted (24 h)
Number of subjects: 25
Study 34542418 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy using VR in the form of head-mounted displays (HMDs)
Number of subjects: 43
Study 34542418 — intervention group
Group type: COMPARATOR
Intervention: Reminiscence therapy using a laptop computer supplemented by physical items (active control)
Number of subjects: 43
Study 34542418 — intervention group
Group type: COMPARATOR
Intervention: Pooled apathy scores in the two intervention groups (VR and laptop)
Number of subjects: 43
Study 34542418 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes (cognition and depression)
Number of subjects: 43
Study 34542418 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 43
Study 32353573 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person counseling (PE)
Number of subjects: 960
Study 32353573 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated written feedback (CO)
Number of subjects: 960
Study 32353573 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (AO)
Number of subjects: 960
Study 36399349 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a barrier membrane with a mixture of mineralized and demineralized allografts
Number of subjects: 33
Study 36399349 — intervention group
Group type: COMPARATOR
Intervention: Mixture of mineralized and demineralized allografts without barrier membrane
Number of subjects: 33
Study 36399349 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified plaque index at T0
Number of subjects: 33
Study 36399349 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratinized mucosa width
Number of subjects: 33
Study 36399349 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (women)
Number of subjects: 33
Study 33993175 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondysmorphic pelvises
Number of subjects: 267
Study 33993175 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysmorphic pelvises
Number of subjects: 267
Study 32666477 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA (ursodeoxycholic acid)
Number of subjects: 209
Study 32666477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 36111378 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.50 μg/kg
Number of subjects: 80
Study 36111378 — intervention group
Group type: COMPARATOR
Intervention: Nalbuphine 0.08 mg/kg
Number of subjects: 80
Study 34126774 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application-based health SBIRT
Number of subjects: 12
Study 34126774 — intervention group
Group type: COMPARATOR
Intervention: SBIRT-Conventional Training and Supervision
Number of subjects: 12
Study 36088659 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste-neutral (water)
Number of subjects: 297
Study 36088659 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter (quinine)
Number of subjects: 297
Study 36088659 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet (saccharin)
Number of subjects: 297
Study 36088659 — intervention group
Group type: COMPARATOR
Intervention: No placebo drops
Number of subjects: 297
Study 33060389 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with a balloon‐expandable valve
Number of subjects: 0
Study 33060389 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 0
Study 33586453 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-ICH antiplatelet therapy
Number of subjects: 2325
Study 33586453 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325
Study 32486805 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-Visual (AV) conditions
Number of subjects: 12
Study 32486805 — intervention group
Group type: COMPARATOR
Intervention: Auditory-Only (AO) conditions
Number of subjects: 12
Study 33676009 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medial prefrontal cortex high-definition transcranial direct current stimulation (HD-tDCS) for 3 consecutive days (20 minutes each session)
Number of subjects: 12
Study 33676009 — intervention group
Group type: COMPARATOR
Intervention: Sham medial prefrontal cortex high-definition transcranial direct current stimulation (HD-tDCS) for 3 consecutive days (20 minutes each session)
Number of subjects: 12
Study 33676009 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 12
Study 33994515 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-visit occupational therapy using Management Tool for Daily Life Performance (MTDLP)
Number of subjects: 60
Study 33994515 — intervention group
Group type: COMPARATOR
Intervention: Home-visit occupational therapy without using MTDLP (Control)
Number of subjects: 60
Study 32558913 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth Care Without a Battle program
Number of subjects: 2152
Study 32558913 — intervention group
Group type: COMPARATOR
Intervention: Standard mouth care (control)
Number of subjects: 2152
Study 32972114 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Stupp protocol (concomitant chemoradiation)
Number of subjects: 6390
Study 32972114 — intervention group
Group type: COMPARATOR
Intervention: Pre-Stupp protocol (no concomitant chemoradiation)
Number of subjects: 6390
Study 32363944 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtheoretical model‐based walking exercise training
Number of subjects: 152
Study 33028623 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (arm A)
Number of subjects: 171
Study 33028623 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy followed by interval debulking surgery (arm B)
Number of subjects: 171
Study 33549429 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin coconut oil (VCO) 30 ml per day for four weeks
Number of subjects: 48
Study 36305459 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapeutic plasma exchange (TPE) with albumin replacement
Number of subjects: 1283
Study 36305459 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume plasma exchange (LVPE) with albumin replacement
Number of subjects: 1283
Study 36305459 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham PE treatment)
Number of subjects: 1283
Study 36305459 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous access in active treatment groups
Number of subjects: 1283
Study 36305459 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral venous access in active treatment groups
Number of subjects: 1283
Study 34905446 — intervention group
Group type: EXPERIMENTAL
Intervention: EV71 vaccine (dose 1) and MMR on d 0 and EV71 vaccine (dose 2) and LA‐JEV on d 30 (Group 1)
Number of subjects: 372
Study 34905446 — intervention group
Group type: COMPARATOR
Intervention: Administration of doses 1 and 2 of EV71 vaccine on d 0 and 30, respectively (Group 3)
Number of subjects: 372
Study 34905446 — intervention group
Group type: COMPARATOR
Intervention: MMR and LA‐JEV on d 0 and 30, respectively (Group 2)
Number of subjects: 372
Study 32960998 — intervention group
Group type: EXPERIMENTAL
Intervention: eDiary documentation of bowel movements and fecal incontinence episodes, prompted by twice-daily phone notifications, with adherence rates of 95% and notifications prompting 29.6% of entries.
Number of subjects: 60
Study 32960998 — intervention group
Group type: COMPARATOR
Intervention: paper diary documentation of bowel movements and fecal incontinence episodes.
Number of subjects: 60
Study 34711086 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower portion of the yellow zone (YZ)
Number of subjects: 120
Study 34711086 — intervention group
Group type: COMPARATOR
Intervention: Upper portion of the red zone (RZ)
Number of subjects: 120
Study 34711086 — intervention group
Group type: COMPARATOR
Intervention: Green zone (GZ)
Number of subjects: 120